Abstract
Keeping in view the potential of heterocyclic fused quinazolones and arylidene linked heterocycles , hybrid molecules of these functionalities were designed and synthesised. All the synthesised molecules were characterized by spectroscopic techniques and evaluated for antimicrobial activity against 2 Gram positive bacterial strains; Staphylococcus aureus (MTCC 96) and Bacillus subtilis (MTCC 2451), 3 Gram negative bacterial strains; Escherichia coli (MTCC 82), Pseudomonas aeruginosa (MTCC 2642) and Salmonella typhimurium (MTCC 1251) and 2 fungal strains; Saccharomyces cerevisiae (MTCC 2799) and Candida albicans (MTCC 3018). Among the synthesised molecules, arylidene pyrrolo fused quinazolones displayed significant antimicrobial activity in comparison to arylidene pyrido fused quinazolones. The influence of the electronic factors linked with the arylidene ring was also observed on the antimicrobial potential. Thus the present study highlights the potential of such hybrid molecules as a new class of antimicrobials.
Keywords: Antimicrobial, Quinazoline, Strains, Quinazoline, Pyrrolo, Pyrido.
Letters in Drug Design & Discovery
Title:Design, Synthesis and Evaluation of Arylidene Pyrrolo and Pyrido Fused Quinazolones as Antimicrobial Agents
Volume: 10 Issue: 6
Author(s): Kunal Nepali, Ritu Ojha, Aninder Singh, Abhishek Budhiraja, Preet Mohinder Singh Bedi and Kanaya Lal Dhar
Affiliation:
Keywords: Antimicrobial, Quinazoline, Strains, Quinazoline, Pyrrolo, Pyrido.
Abstract: Keeping in view the potential of heterocyclic fused quinazolones and arylidene linked heterocycles , hybrid molecules of these functionalities were designed and synthesised. All the synthesised molecules were characterized by spectroscopic techniques and evaluated for antimicrobial activity against 2 Gram positive bacterial strains; Staphylococcus aureus (MTCC 96) and Bacillus subtilis (MTCC 2451), 3 Gram negative bacterial strains; Escherichia coli (MTCC 82), Pseudomonas aeruginosa (MTCC 2642) and Salmonella typhimurium (MTCC 1251) and 2 fungal strains; Saccharomyces cerevisiae (MTCC 2799) and Candida albicans (MTCC 3018). Among the synthesised molecules, arylidene pyrrolo fused quinazolones displayed significant antimicrobial activity in comparison to arylidene pyrido fused quinazolones. The influence of the electronic factors linked with the arylidene ring was also observed on the antimicrobial potential. Thus the present study highlights the potential of such hybrid molecules as a new class of antimicrobials.
Export Options
About this article
Cite this article as:
Nepali Kunal, Ojha Ritu, Singh Aninder, Budhiraja Abhishek, Bedi Preet Mohinder Singh and Dhar Kanaya Lal, Design, Synthesis and Evaluation of Arylidene Pyrrolo and Pyrido Fused Quinazolones as Antimicrobial Agents, Letters in Drug Design & Discovery 2013; 10 (6) . https://dx.doi.org/10.2174/1570180811310060008
DOI https://dx.doi.org/10.2174/1570180811310060008 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Triazole as Potent Anti-cancer Agent- A Pharmacophoric Scaffold
Current Cancer Therapy Reviews In Vitro Solubility Assays in Drug Discovery
Current Drug Metabolism Radar Cross Section Identification of Air Targets using the Cosine Transform and Neural Networks
Recent Patents on Engineering Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine
CNS & Neurological Disorders - Drug Targets Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysautonomia
Current Drug Targets Review of Theoretical Studies for Prediction of Neurodegenerative Inhibitors
Mini-Reviews in Medicinal Chemistry Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
Current Medicinal Chemistry Alveolar Cell Wounding by Deforming Stress in the Lung
Current Respiratory Medicine Reviews Antibody-drug Conjugate Targets, Drugs, and Linkers
Current Cancer Drug Targets The ORL-1 Receptor System: Are There Opportunities for Antagonists in Pain Therapy?
Current Topics in Medicinal Chemistry Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors
Current Topics in Medicinal Chemistry Interleukin-1 in Coronary Artery Disease
Current Topics in Medicinal Chemistry Weaning and Extubation in Pediatrics
Current Respiratory Medicine Reviews Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes
Mini-Reviews in Medicinal Chemistry Melanotropins as Drugs for the Treatment of Obesity and Other Feeding Disorders: Potential and Problems
Current Topics in Medicinal Chemistry Biomedical Devices for Pathogen Detection Using Microfluidic Chips
Current Proteomics Advances in Spirocyclic Hybrids: Chemistry and Medicinal Actions
Current Medicinal Chemistry Effects of Elicitors, Viticultural Factors, and Enological Practices on Resveratrol and Stilbenes in Grapevine and Wine
Mini-Reviews in Medicinal Chemistry Human Opiorphin an Endogenous Inhibitor of Enkephalin-Inactivating Ectopeptidases that Displays Antinociception: A Review
Current Bioactive Compounds The Beneficial Effects of QIAPI 1<sup>®</sup> against Pentavalent Arsenic-Induced Lung Toxicity: A Hypothetical Model for SARS CoV2-I nduced Lung Toxicity
Current Pharmaceutical Biotechnology